Aryaka Launches the first Clientless SD-WAN
Aryaka Announces General Availability of SmartACCESS - the first-to-market SD-WAN for remote access, with built-in dynamic CDN
SAN MATEO, Calif., June 15, 2017 (GLOBE NEWSWIRE) -- Aryaka®, the leading global SD-WAN provider, announced today the launch of SmartACCESS, the first-to-market clientless SD-WAN solution with built-in dynamic CDN to deliver:
- Up to 3 times faster application performance for remote and mobile users
- Consolidated and simplified VPN infrastructure
- Enhanced security and visibility of all remote and mobile user activity
- Global deployment in hours, with the ability to scale in minutes
While SD-WAN technologies have been making inroads into enterprise branch offices and datacenters, remote access has been a key missing link due to SD-WANs' mandatory appliances, leaving remote and mobile users struggling with poor application performance and slow access to corporate resources, translating into lost productivity.
Aryaka is the first company to address these performance challenges by software-defining remote access. SmartACCESS significantly enhances both on-premises and cloud/SaaS application performance for the remote and mobile workforce without requiring additional hardware or software clients. To achieve that, Aryaka, for the first time, has integrated Dynamic CDN functionality into SD-WAN.
"Global enterprises are increasingly struggling with real-time application performance, especially for remote and mobile users. This adversely impacts productivity and increases costs as well as complexity for IT," said Shawn Farshchi, Aryaka's President and CEO. "We're excited to introduce the first solution to software-define remote access, by combining Aryaka's global SD-WAN and dynamic CDN capabilities to deliver faster performance for enterprise remote access without requiring any additional software clients or appliances."
"Remote access is critical to any large enterprise. Network latency and overall application performance are the Achilles heel of the remote and mobile workforce, hampering productivity and exacerbated by overseas travel," said Jennifer Clark, Vice President, Network Research at 451 Research. "Enterprises are looking for options, such as Aryaka's SmartACCESS, that leverage the performance, cost and flexibility of SD-WAN, but are clientless and able to extend its benefits to the mobile workforce, seamlessly."
Global Private Network enables remote and mobile employees to bypass the bottlenecks and unpredictability of the public Internet.
WAN Optimization accelerates application delivery.
Dynamic IP App Acceleration accelerates all IP-based traffic to global users (application-agnostic acceleration).
Intelligent DNS-Based Routing automatically connects mobile and remote employees to the most optimal POP for the best application performance.
Global Load Balancing enables remote and mobile employees to use a single domain name to connect to the VPN concentrator (and corporate resources) without having to change local VPN settings or worrying about where they are.
- BYOD Support enables faster delivery of applications to all devices and operating systems.
Platform Specialty Products Saves $100,000 Annually with Aryaka's SmartACCESS
Platform Specialty Products (PSP) (NYSE:PAH), one of the early adopters of SmartACCESS, is a global, high-tech specialty chemical company with 40 percent remote and mobile employees. They were looking to significantly enhance performance of both on-premises and cloud/SaaS applications for their remote workforce, while reducing their complexity of having to manage 50 VPN concentrators globally.
Aryaka SmartACCESS enabled PSP to:
- Improve application performance for remote and mobile users delivering up to several hundred milliseconds reduction in client-server setup times
- Reduce their 50 VPN concentrators around the world down to 4
- Save over $100,000 in operational costs annually
- Raise productivity for sales, marketing, and IT by 20-30%
"The ability of Aryaka's SmartACCESS to centralize and control the environment better and reduce the number of control sets you have to run for various audit purposes is the biggest benefit," said Dustin Collins, VP of Global Infrastructure Services at PSP.
SmartACCESS is now available to Aryaka's customers globally, and has been deployed in full production by 15 large global enterprises. To learn more, visit http://www.aryaka.com/services/smartaccess.
Aryaka is transforming how global enterprises connect sites and users worldwide, and use mission-critical applications to support modern business execution demands. Aryaka's Global SD-WAN combines a purpose-built private network, SD-WAN, optimization and acceleration techniques, connectivity to cloud platforms, and network visibility in a single solution that is delivered as a service.
Aryaka Media Contact: Shehzad Karkhanawala Public Relations Manager Aryaka 408.273.8420 firstname.lastname@example.org
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Aryaka via Globenewswire
Följ NASDAQ OMX
Skriv in din e-postadress så får du ett mejl när vi har något nytt att berätta.
Senaste pressmeddelandena från NASDAQ OMX
XBiotech Announces First Patient in Study Evaluating MABp1 in Combination with Onivyde® and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer18.10.2017 16:53 | Pressmeddelande
AUSTIN, Texas, Oct. 18, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today enrollment of the first patient into a Phase I single arm study evaluating the maximum tolerated dose of Onivyde® (Irinotecan liposome injection) and 5-fluorouracil/folinic acid in combination with MABp1 in a cohort of patients with advanced pancreatic adenocarcinoma and cachexia. The patient has begun treatment at Cedars-Sinai Medical Center under the care of Dr. Andrew Hendifar, the Study's Principle Investigator, Medical Oncology lead for the Gastrointestinal Disease Research Group and Co-Director of Pancreas Oncology at Cedars-Sinai. A total of 16 patients are expected to be enrolled in the study. Dr. Hendifar commented, "We are excited to enroll our first patient in this novel combinatorial therapy for the treatment of advanced pancreatic cancer and cachexia. This is the first attempt to add an anti-inflammatory therapy to standard chemotherapy in an effort to improve the performanc
Nasdaq and SGX Establish Collaborative Listings Agreement18.10.2017 15:42 | Pressmeddelande
NEW YORK and SINGAPORE, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Nasdaq Inc. (Nasdaq:NDAQ) and Singapore Exchange (SGX) today announced the signing of a collaborative agreement in a move to leverage their strengths as two of the leading listings venues in the U.S. and Asia respectively. The new agreement seeks to enhance the channels available for companies to access capital market funding and enhance their corporate profile in both markets. As part of this agreement, Nasdaq and SGX -- who also share a successful, long-term market technology relationship -- are currently exploring the demand among corporates for a concurrent or sequential listing on both exchanges. Nasdaq and SGX are committed to supporting companies that are interested in pursuing this route. "The business landscape today is borderless," said Loh Boon Chye, CEO, SGX. "Fast-growing Asian companies looking to tap the capital markets can choose to list on SGX on Asian home ground, and embark on a listing on Nasdaq
Momentum Group acquires remaining 70 percent of Knut Sehlins Industrivaruhus in Örnsköldsvik18.10.2017 15:00 | Pressmeddelande
TOOLS Sweden (part of Momentum Group) has owned 30 percent of the shares in Knut Sehlins Industrivaruhus AB ("Sehlins") in Örnsköldsvik, Sweden since 2007. Today, TOOLS acquired the remaining 70 percent of the shares in Sehlins, which thus becomes a wholly owned subsidiary. Sehlins generates annual revenue of approximately MSEK 40 and has 14 employees. Sehlins is one of the leading industrial resellers in Örnsköldsvik, an attractive and important market with a number of successful industrial companies. The aim of the acquisition for TOOLS is to continue developing Sehlins as a wholly owned business with a focus on delivering optimal service for existing and potential customers in the local market. Sehlins has been part of TOOLS since the chain was formed in 2003. Closing takes place in October 2017. The acquisition is expected to have a marginal impact on Momentum Group's earnings per share during the current financial year. Stockholm, 18 October 2017
Momentum Group förvärvar resterande 70 procent av Knut Sehlins Industrivaruhus i Örnsköldsvik18.10.2017 15:00 | Pressmeddelande
TOOLS Sverige (inom Momentum Group-koncernen) är sedan 2007 delägare med 30 procent av aktierna i Knut Sehlins Industrivaruhus AB ("Sehlins") i Örnsköldsvik. TOOLS har idag förvärvat resterande 70 procent av aktierna i Sehlins, vilket härigenom blir ett helägt dotterbolag. Sehlins omsätter cirka 40 MSEK per år och har 14 anställda. Sehlins är en av de ledande industriåterförsäljarna i Örnsköldsvik, en intressant och viktig marknad med ett antal framgångsrika industriföretag. Syftet med TOOLS förvärv är att fortsätta utveckla Sehlins som en helägd verksamhet med fokus på att serva nuvarande och potentiella kunder på den lokala marknaden på bästa sätt. Sehlins har varit en del av TOOLS sedan starten av kedjan 2003. Tillträde sker i oktober 2017. Förvärvet bedöms ha en marginell påverkan på Momentum Groups resultat per aktie under innevarande räkenskapsår. Stockholm den 18 oktober 2017 Momentum Group AB (publ) För ytterligare inf
Colliers International Expands in Washington, D.C.18.10.2017 14:30 | Pressmeddelande
Acquisition of Beltway Real Estate Services Firm Strengthens Ongoing Commitment to the Region TORONTO and WASHINGTON, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Leading global commercial real estate services firm Colliers International Group Inc. (NASDAQ:CIGI)(TSX:CIGI) announced today the acquisition of leading tenant representation advisory firm Serten Advisors. With its office in Tysons Corner, the firm serves global, national, and regional clients with a highly skilled and experienced team of professionals that have more than 100 years of combined experience. "This strategic acquisition positions Colliers to gain additional market share and win new business in the vibrant and competitive Suburban DC markets," said Marty Pupil, Colliers International President | U.S. Brokerage. "Adding Steve and Paul and the rest of their talented leadership team to our existing group of professionals in the region will further position Colliers as the commercial real estate services firm of
InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC18.10.2017 14:00 | Pressmeddelande
InSphero AG / InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. New 3D InSight(TM) Human Liver Fibrosis Model represents a powerful tool for screening efficacy and safety of anti-fibrotic drugs in vitro. Schlieren, Switzerland, Oct. 18, 2017 (GLOBE NEWSWIRE) -- InSphero AG, the leading supplier of assay-ready 3D cell culture models for accelerating drug discovery and development, will present data characterizing and demonstrating the utility of its new 3D InSight(TM) Human Liver Fibrosis Model for screening efficacy of anti-fibrotic drugs. The findings will be presented at oral and poster presentations this Friday at the annual meeting of the American Association for the Study of Liver Disease (AASLD) Conference in Washington, DC. Anti-fibrotic therapi
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum